Actuate Therapeutics, Inc. · NASDAQ:ACTU
Voss Capital, LP reported a 5.30% stake in Actuate Therapeutics, Inc. (Schedule 13G)
Event Dec 15, 2025 · Filed Dec 17, 2025
Voss Capital, LP reported a 5.30% stake in Actuate Therapeutics, Inc., 1,227,756 shares, as a passive investor on Dec 15, 2025. Filed Dec 17, 2025 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 1,227,756
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Voss Capital, LP | 5.30% | 1,227,756 |
| Cocke Travis W. | 5.30% | 1,227,756 |
| Voss Advisors GP, LLC | 1.10% | 250,000 |
| Voss Value Master Fund, LP | 0.90% | 200,000 |
| Voss Value-Oriented Special Situations Fund, LP | 0.20% | 50,000 |